WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke IDSIQ wurde als Wortmarke am 30.12.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1584862 |
| Registernummer | 754999 |
| Länder | 
|
| Basismarke |
Nr. 754999,
02. November 2020
|
| Anmeldedatum | 30. Dezember 2020 |
| Ablaufdatum | 30. Dezember 2030 |
Markeninhaber
Markenvertreter
Beethovenstrasse 49,
P.O. Box
CH
Waren und Dienstleistungen
09
Electronic publications (downloadable) in the field of
medical tests which are used for identifying symptoms of
insomnia in patients and the effects of insomnia disorders
on patients or symptoms of mental disorders associated with
insomnia in patients and the effects of mental disorders
associated with insomnia disorders on patients and in the
field of collection of medical data which are used for
identifying symptoms of insomnia in patients and the effects
of insomnia disorders on patients or symptoms of mental
disorders associated with insomnia in patients and the
effects of mental disorders associated with insomnia
disorders on patients
16
Printed matter (publications) in the field of medical tests
which are used for identifying symptoms of insomnia in
patients and the effects of insomnia disorders on patients
or symptoms of mental disorders associated with insomnia in
patients and the effects of mental disorders associated with
insomnia disorders on patients and in the field of
collection of medical data which are used for identifying
symptoms of insomnia in patients and the effects of insomnia
disorders on patients or symptoms of mental disorders
associated with insomnia in patients and the effects of
mental disorders associated with insomnia disorders on
patients
41
Multimedia publication of printed matter in the field of
medical tests which are used for identifying symptoms of
insomnia in patients and the effects of insomnia disorders
on patients or symptoms of mental disorders associated with
insomnia in patients and the effects of mental disorders
associated with insomnia disorders on patients and in the
field of collection of medical data which are used for
identifying symptoms of insomnia in patients and the effects
of insomnia disorders on patients or symptoms of mental
disorders associated with insomnia in patients and the
effects of mental disorders associated with insomnia
disorders on patients; multimedia publication of printed
matter in the field of tests which are used for identifying
symptoms of insomnia in patients and the effects of insomnia
disorders on patients or symptoms of mental disorders
associated with insomnia in patients and the effects of
mental disorders associated with insomnia disorders on
patients and in the field of collection of medical data
which are used for identifying symptoms of insomnia in
patients and the effects of insomnia disorders on patients
or symptoms of mental disorders associated with insomnia in
patients and the effects of mental disorders associated with
insomnia disorders on patients
42
Scientific research and development, namely pharmaceutical
and medical testing services and development of
pharmaceutical and medical tests which are used for
identifying symptoms of insomnia in patients and the effects
of insomnia disorders on patients or symptoms of mental
disorders associated with insomnia in patients and the
effects of mental disorders associated with insomnia
disorders on patients; scientific research, namely analysis
of objective data on patients by means of diagnostic tests
in the context of drug administration, analysis of
subjective data on patients by means of patient questioning,
analysis of such data with the aim of optimizing drug
treatments and drug administration
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 21. September 2022 | 2022/40 Gaz | IS | Ablehnung |
| 19. September 2022 | 2023/5 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 09. September 2022 | 2022/37 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 20. Juli 2022 | 2022/29 Gaz | CA | Ablehnung |
| 04. Juli 2022 | 2022/27 Gaz | MX | Ablehnung |
| 20. April 2022 | 2022/16 Gaz | NO | Ablehnung |
| 01. April 2022 | 2022/14 Gaz | LI | Ablehnung |
| 17. März 2022 | 2022/11 Gaz | KR | Ablehnung |
| 10. Februar 2022 | 2022/6 Gaz | JP | Ablehnung |
| 08. Februar 2022 | 2022/6 Gaz | BR | Ablehnung |
| 03. Februar 2022 | 2022/5 Gaz | UA | Ablehnung |
| 15. Dezember 2021 | 2021/50 Gaz | GB | Ablehnung |
| 05. Dezember 2021 | 2021/49 Gaz | IL | Ablehnung |
| 06. November 2021 | 2021/46 Gaz | NO | Ablehnung |
| 02. November 2021 | 2021/44 Gaz | NZ | Ablehnung |
| 20. Oktober 2021 | 2021/42 Gaz | TR | Ablehnung |
| 11. Oktober 2021 | 2021/41 Gaz | IN | Ablehnung |
| 25. August 2021 | 2021/35 Gaz | EM | Ablehnung |
| 07. August 2021 | 2021/33 Gaz | SG | Ablehnung |
| 05. August 2021 | 2021/31 Gaz | CN | Ablehnung |
| 26. Juli 2021 | 2021/30 Gaz | US | Ablehnung |
| 29. Juni 2021 | 2021/26 Gaz | AU | Ablehnung |
| 14. Juni 2021 | 2021/24 Gaz | RU | Ablehnung |
| 30. Dezember 2020 | 2021/12 Gaz | CH | Eintragung |
ID: 141584862